206 related articles for article (PubMed ID: 30187809)
1. OncomiR or antioncomiR: Role of miRNAs in Acute Myeloid Leukemia.
He C; Luo B; Jiang N; Liang Y; He Y; Zeng J; Liu J; Zheng X
Leuk Lymphoma; 2019 Feb; 60(2):284-294. PubMed ID: 30187809
[TBL] [Abstract][Full Text] [Related]
2. miRNAs in acute myeloid leukemia.
Liao Q; Wang B; Li X; Jiang G
Oncotarget; 2017 Jan; 8(2):3666-3682. PubMed ID: 27705921
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs as New Biomarkers for Diagnosis and Prognosis, and as Potential Therapeutic Targets in Acute Myeloid Leukemia.
Trino S; Lamorte D; Caivano A; Laurenzana I; Tagliaferri D; Falco G; Del Vecchio L; Musto P; De Luca L
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29401684
[TBL] [Abstract][Full Text] [Related]
4. MicroRNAs Associated With a Good Prognosis of Acute Myeloid Leukemia and Their Effect on Macrophage Polarization.
Neaga A; Bagacean C; Tempescul A; Jimbu L; Mesaros O; Blag C; Tomuleasa C; Bocsan C; Gaman M; Zdrenghea M
Front Immunol; 2020; 11():582915. PubMed ID: 33519805
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA function in cancer: oncogene or a tumor suppressor?
Shenouda SK; Alahari SK
Cancer Metastasis Rev; 2009 Dec; 28(3-4):369-78. PubMed ID: 20012925
[TBL] [Abstract][Full Text] [Related]
6. New insight into the role of miRNAs in leukemia.
Zhang H; Chen Y
Sci China C Life Sci; 2009 Mar; 52(3):224-31. PubMed ID: 19294347
[TBL] [Abstract][Full Text] [Related]
7. The prognostic and functional role of microRNAs in acute myeloid leukemia.
Marcucci G; Mrózek K; Radmacher MD; Garzon R; Bloomfield CD
Blood; 2011 Jan; 117(4):1121-9. PubMed ID: 21045193
[TBL] [Abstract][Full Text] [Related]
8. Role of microRNAs, circRNAs and long noncoding RNAs in acute myeloid leukemia.
Liu Y; Cheng Z; Pang Y; Cui L; Qian T; Quan L; Zhao H; Shi J; Ke X; Fu L
J Hematol Oncol; 2019 May; 12(1):51. PubMed ID: 31126316
[TBL] [Abstract][Full Text] [Related]
9. miR signatures and the role of miRs in acute myeloid leukaemia.
Seca H; Almeida GM; Guimarães JE; Vasconcelos MH
Eur J Cancer; 2010 Jun; 46(9):1520-7. PubMed ID: 20413298
[TBL] [Abstract][Full Text] [Related]
10. T-cell acute lymphoblastic leukemia from miRNA perspective: Basic concepts, experimental approaches, and potential biomarkers.
Drobna M; Szarzyńska-Zawadzka B; Dawidowska M
Blood Rev; 2018 Nov; 32(6):457-472. PubMed ID: 29703513
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs and acute myeloid leukemia: therapeutic implications and emerging concepts.
Wallace JA; O'Connell RM
Blood; 2017 Sep; 130(11):1290-1301. PubMed ID: 28751524
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Resistance in Acute Myeloid Leukemia: The Role of Non-Coding RNAs.
Zebisch A; Hatzl S; Pichler M; Wölfler A; Sill H
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27973410
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-based therapies: Revolutionizing the treatment of acute myeloid leukemia.
Chandraprabha Vineetha R; Anitha Geetha Raj J; Devipriya P; Sreelatha Mahitha M; Hariharan S
Int J Lab Hematol; 2024 Feb; 46(1):33-41. PubMed ID: 38105344
[TBL] [Abstract][Full Text] [Related]
14. The pathological role and prognostic impact of miR-181 in acute myeloid leukemia.
Weng H; Lal K; Yang FF; Chen J
Cancer Genet; 2015 May; 208(5):225-9. PubMed ID: 25686674
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis the potential biomarkers for the high-risk of childhood acute myeloid leukemia based on a competing endogenous RNA network.
Zhang N; Chen Y; Shen Y; Lou S; Deng J
Blood Cells Mol Dis; 2019 Nov; 79():102352. PubMed ID: 31404908
[TBL] [Abstract][Full Text] [Related]
16. miRNAs in Melanoma: Tumor Suppressors and Oncogenes with Prognostic Potential.
Wozniak M; Mielczarek A; Czyz M
Curr Med Chem; 2016; 23(28):3136-3153. PubMed ID: 27666934
[TBL] [Abstract][Full Text] [Related]
17. Tumor suppressors in acute myeloid leukemia.
Wallwitz J; Aigner P; Stoiber D
Leuk Lymphoma; 2021 Oct; 62(10):2320-2330. PubMed ID: 33929273
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs and tRNA-derived fragments predict the transformation of myelodysplastic syndromes to acute myeloid leukemia.
Guo Y; Strickland SA; Mohan S; Li S; Bosompem A; Vickers KC; Zhao S; Sheng Q; Kim AS
Leuk Lymphoma; 2017 Sep; 58(9):1-15. PubMed ID: 28084850
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of miR-128a induces Lin28a expression and reverts myeloid differentiation blockage in acute myeloid leukemia.
De Luca L; Trino S; Laurenzana I; Tagliaferri D; Falco G; Grieco V; Bianchino G; Nozza F; Campia V; D'Alessio F; La Rocca F; Caivano A; Villani O; Cilloni D; Musto P; Del Vecchio L
Cell Death Dis; 2017 Jun; 8(6):e2849. PubMed ID: 28569789
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanism of microRNA involvement in genesis of myelodysplastic syndrome and its transformation to acute myeloid leukemia.
Liao R; Xu Y; Chen M; Chen X; Zhan X; Sun J
Hematology; 2013 Jul; 18(4):191-7. PubMed ID: 23321417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
